adenosine 5'-methylenediphosphate has been researched along with Pituitary Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, MH; Liu, SI; Wu, SN | 1 |
1 other study(ies) available for adenosine 5'-methylenediphosphate and Pituitary Neoplasms
Article | Year |
---|---|
Cilostazol, an inhibitor of type 3 phosphodiesterase, stimulates large-conductance, calcium-activated potassium channels in pituitary GH3 cells and pheochromocytoma PC12 cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Action Potentials; Adenoma; Adenosine; Adenosine Diphosphate; Animals; Calcium Channels, L-Type; Cilostazol; Cyclic Nucleotide Phosphodiesterases, Type 3; Electric Conductivity; Enzyme Inhibitors; Kinetics; Large-Conductance Calcium-Activated Potassium Channels; PC12 Cells; Phosphodiesterase Inhibitors; Pituitary Gland, Anterior; Pituitary Neoplasms; Potassium Channels, Calcium-Activated; Rats; Tetrazoles | 2004 |